Literature DB >> 17848619

Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells.

Dorothée Duluc1, Yves Delneste, Fang Tan, Marie-Pierre Moles, Linda Grimaud, Julien Lenoir, Laurence Preisser, Ignacio Anegon, Laurent Catala, Norbert Ifrah, Philippe Descamps, Erick Gamelin, Hugues Gascan, Mohamed Hebbar, Pascale Jeannin.   

Abstract

Tumor-associated macrophages (TAMs), the most abundant immunosuppressive cells in the tumor microenvironment, originate from blood monocytes and exhibit an IL-10(high)IL-12(low) M2 profile. The factors involved in TAM generation remain unidentified. We identify here leukemia inhibitory factor (LIF) and IL-6 as tumor microenvironmental factors that can promote TAM generation. Ovarian cancer ascites switched monocyte differentiation into TAM-like cells that exhibit most ovarian TAM functional and phenotypic characteristics. Ovarian cancer ascites contained high concentrations of LIF and IL-6. Recombinant LIF and IL-6 skew monocyte differentiation into TAM-like cells by enabling monocytes to consume monocyte-colony-stimulating factor (M-CSF). Depletion of LIF, IL-6, and M-CSF in ovarian cancer ascites suppressed TAM-like cell induction. We extended these observations to different tumor-cell line supernatants. In addition to revealing a new tumor-escape mechanism associated with TAM generation via LIF and IL-6, these findings offer novel therapeutic perspectives to subvert TAM-induced immunosuppression and hence improve T-cell-based antitumor immunotherapy efficacy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17848619     DOI: 10.1182/blood-2007-02-072587

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  167 in total

1.  Acute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a Growth factor independence 1 dependent manner.

Authors:  Yahya S Al-Matary; Lacramioara Botezatu; Bertram Opalka; Judith M Hönes; Robert F Lams; Aniththa Thivakaran; Judith Schütte; Renata Köster; Klaus Lennartz; Thomas Schroeder; Rainer Haas; Ulrich Dührsen; Cyrus Khandanpour
Journal:  Haematologica       Date:  2016-07-07       Impact factor: 9.941

2.  CD206-positive M2 macrophages that express heme oxygenase-1 protect against diabetic gastroparesis in mice.

Authors:  Kyoung Moo Choi; Purna C Kashyap; Nirjhar Dutta; Gary J Stoltz; Tamas Ordog; Terez Shea Donohue; Anthony J Bauer; David R Linden; Joseph H Szurszewski; Simon J Gibbons; Gianrico Farrugia
Journal:  Gastroenterology       Date:  2010-02-20       Impact factor: 22.682

Review 3.  Immune regulation by non-lymphoid cells in transplantation.

Authors:  A-S Dugast; B Vanhove
Journal:  Clin Exp Immunol       Date:  2009-01-22       Impact factor: 4.330

4.  IL-34 is a Treg-specific cytokine and mediates transplant tolerance.

Authors:  Séverine Bézie; Elodie Picarda; Jason Ossart; Laurent Tesson; Claire Usal; Karine Renaudin; Ignacio Anegon; Carole Guillonneau
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

5.  Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy.

Authors:  Christel Devaud; Jennifer A Westwood; Liza B John; Jacqueline K Flynn; Sophie Paquet-Fifield; Connie P M Duong; Carmen S M Yong; Hollie J Pegram; Steven A Stacker; Marc G Achen; Trina J Stewart; Linda A Snyder; Michele W L Teng; Mark J Smyth; Phillip K Darcy; Michael H Kershaw
Journal:  Mol Ther       Date:  2013-09-19       Impact factor: 11.454

6.  Stem Cell Factor LIFted as a Promising Clinical Target for Cancer Therapy.

Authors:  Yu Shi; Sean Hunter; Tony Hunter
Journal:  Mol Cancer Ther       Date:  2019-08       Impact factor: 6.261

Review 7.  MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response.

Authors:  Kobina Essandoh; Yutian Li; Jiuzhou Huo; Guo-Chang Fan
Journal:  Shock       Date:  2016-08       Impact factor: 3.454

8.  Renalase Expression by Melanoma and Tumor-Associated Macrophages Promotes Tumor Growth through a STAT3-Mediated Mechanism.

Authors:  Lindsay Hollander; Xiaojia Guo; Heino Velazquez; John Chang; Robert Safirstein; Harriet Kluger; Charles Cha; Gary V Desir
Journal:  Cancer Res       Date:  2016-05-09       Impact factor: 12.701

9.  The ecto-ATPDase CD39 is involved in the acquisition of the immunoregulatory phenotype by M-CSF-macrophages and ovarian cancer tumor-associated macrophages: Regulatory role of IL-27.

Authors:  Sènan M d'Almeida; Gilles Kauffenstein; Charlotte Roy; Laetitia Basset; Loukas Papargyris; Daniel Henrion; Véronique Catros; Norbert Ifrah; Philippe Descamps; Anne Croue; Pascale Jeannin; Marc Grégoire; Yves Delneste; Julie Tabiasco
Journal:  Oncoimmunology       Date:  2016-04-28       Impact factor: 8.110

10.  Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia.

Authors:  Li Jia; Andrew Clear; Feng-Ting Liu; Janet Matthews; Nadiha Uddin; Aine McCarthy; Elena Hoxha; Catherine Durance; Sameena Iqbal; John G Gribben
Journal:  Blood       Date:  2014-01-24       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.